Your browser doesn't support javascript.
loading
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes.
Brissova, Marcela; Haliyur, Rachana; Saunders, Diane; Shrestha, Shristi; Dai, Chunhua; Blodgett, David M; Bottino, Rita; Campbell-Thompson, Martha; Aramandla, Radhika; Poffenberger, Gregory; Lindner, Jill; Pan, Fong Cheng; von Herrath, Matthias G; Greiner, Dale L; Shultz, Leonard D; Sanyoura, May; Philipson, Louis H; Atkinson, Mark; Harlan, David M; Levy, Shawn E; Prasad, Nripesh; Stein, Roland; Powers, Alvin C.
Afiliación
  • Brissova M; Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: marcela.brissova@vanderbilt.edu.
  • Haliyur R; Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA.
  • Saunders D; Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA.
  • Shrestha S; HudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.
  • Dai C; Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Blodgett DM; Department of Medicine, Diabetes Division, Diabetes Center of Excellence, University of Massachusetts Medical School, Worcester, MA, USA; Math and Science Division, Babson College, Wellesley, MA 02457, USA.
  • Bottino R; Institute of Cellular Therapeutics, Allegheny-Singer Research Institute, Allegheny Health Network, Pittsburgh, PA, USA.
  • Campbell-Thompson M; Department of Pathology, University of Florida Diabetes Institute, College of Medicine, Gainesville, FL, USA.
  • Aramandla R; Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Poffenberger G; Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Lindner J; Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Pan FC; Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, USA.
  • von Herrath MG; Type 1 Diabetes Center, the La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.
  • Greiner DL; Department of Medicine, Diabetes Division, Diabetes Center of Excellence, University of Massachusetts Medical School, Worcester, MA, USA.
  • Shultz LD; The Jackson Laboratory, Bar Harbor, ME, USA.
  • Sanyoura M; Departments of Medicine and Pediatrics, Section of Endocrinology, Diabetes, and Metabolism, University of Chicago, Chicago, IL, USA.
  • Philipson LH; Departments of Medicine and Pediatrics, Section of Endocrinology, Diabetes, and Metabolism, University of Chicago, Chicago, IL, USA.
  • Atkinson M; Department of Pathology, University of Florida Diabetes Institute, College of Medicine, Gainesville, FL, USA.
  • Harlan DM; Department of Medicine, Diabetes Division, Diabetes Center of Excellence, University of Massachusetts Medical School, Worcester, MA, USA.
  • Levy SE; HudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.
  • Prasad N; HudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.
  • Stein R; Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, USA.
  • Powers AC; Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA; Department of Veterans Affairs, Tennessee Valley Healthcare System, Nash
Cell Rep ; 22(10): 2667-2676, 2018 03 06.
Article en En | MEDLINE | ID: mdl-29514095
ABSTRACT
Many patients with type 1 diabetes (T1D) have residual ß cells producing small amounts of C-peptide long after disease onset but develop an inadequate glucagon response to hypoglycemia following T1D diagnosis. The features of these residual ß cells and α cells in the islet endocrine compartment are largely unknown, due to the difficulty of comprehensive investigation. By studying the T1D pancreas and isolated islets, we show that remnant ß cells appeared to maintain several aspects of regulated insulin secretion. However, the function of T1D α cells was markedly reduced, and these cells had alterations in transcription factors constituting α and ß cell identity. In the native pancreas and after placing the T1D islets into a non-autoimmune, normoglycemic in vivo environment, there was no evidence of α-to-ß cell conversion. These results suggest an explanation for the disordered T1D counterregulatory glucagon response to hypoglycemia.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Regulación de la Expresión Génica / Diabetes Mellitus Tipo 1 / Células Secretoras de Glucagón Tipo de estudio: Observational_studies Límite: Adolescent / Adult / Animals / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Cell Rep Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Regulación de la Expresión Génica / Diabetes Mellitus Tipo 1 / Células Secretoras de Glucagón Tipo de estudio: Observational_studies Límite: Adolescent / Adult / Animals / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Cell Rep Año: 2018 Tipo del documento: Article